These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. Kowalski RP, Dhaliwal DK, Karenchak LM, Romanowski EG, Mah FS, Ritterband DC, Gordon YJ. Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804 [Abstract] [Full Text] [Related]
4. Streptococcus pneumoniae: susceptibility to penicillin and moxifloxacin. Rossi F, Franco MR, Rodrigues HM, Andreazzi D. J Bras Pneumol; 2012 Sep; 38(1):66-71. PubMed ID: 22407042 [Abstract] [Full Text] [Related]
5. [In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin]. Rodríguez-Avial I, Rodríguez-Avial C, Picazo JJ. Rev Esp Quimioter; 2001 Dec; 14(4):364-8. PubMed ID: 11856983 [Abstract] [Full Text] [Related]
6. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents. Kosowska-Shick K, Credito K, Pankuch GA, Lin G, Bozdogan B, McGhee P, Dewasse B, Choi DR, Ryu JM, Appelbaum PC. Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567 [Abstract] [Full Text] [Related]
20. Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000. White RL, Enzweiler KA, Friedrich LV, Wagner D, Hoban D, Bosso JA. Diagn Microbiol Infect Dis; 2002 Jul; 43(3):207-17. PubMed ID: 12106954 [Abstract] [Full Text] [Related] Page: [Next] [New Search]